Recruiting & Admissions
+49 69 798 33501
Das Curriculum des englischsprachigen Programms besteht aus vier wesentlichen Abschnitten. Neben einer hohen praxisorientierten Ausrichtung werden auch ethische Problemstellungen in den Modulen behandelt.
Die Pflichtmodule der Basisphase (Foundation, 4 x 6 CP) schaffen eine solide Grundlage in relevanten Management- und betriebswirtschaftlichen Themenbereichen, abgestimmt auf praktischen Spezifika der Pharmaindustrie.
This module focuses on the comprehensive analysis of management control system as an essential function of management to ensure that the organization’s objectives and strategies are carried out effectively.
The course focuses on the vital role of employees in an enterprise, organizational behavior, and importance of motivation. This course attempts to build understanding and skills in leading and managing people and organizations.
The module focuses on fundamental questions important for understanding corporate finance. Course participants will learn basic concepts related to assessment of investments and financing of corporations. The course introduces key concepts based on modern finance theory such as
This module introduces concepts related to strategic analysis and development. We will discuss different methods of strategic analysis, including such topics as:
Die Pflichtmodule der Vertiefungsphase (Concentration, 4 x 5 CP) vertiefen ausgewählte Management-Themen im Kontext der Pharmaindustrie und geben einen Überblick über die pharmazeutische Wertschöpfungskette.
The course “Innovation Management & Pricing” will familiarize participants with the basic concepts of innovation management and pricing in a pharmaceutical context.
The first part of the module covers innovation management. The class is focused on a set of frameworks and tools to effectively identify, build and commercialize innovations within the firm. A particular focus is set on diagnosing potential failures before they can occur and examine best-case organizations that excel at managing innovations.
In the pricing part of the module, participants will be introduced to the most important concepts and methods to determine prices for existing products as well as product innovations in a pharmaceutical context. We will discuss pricing strategy as well as pricing implementation issues and focus especially on pricing opportunities after the end of the patent term.
The course “High Performance Teams” will give students a totally fresh perspective on team development and how to reach both an individual and collective peak performance. This highly interactive course will shed light on the components that make up the true identity of an individual and how this identity consequently influences communication, decision-making and performance. In order to reach a profound understanding of these concepts, newest findings from neuroscience with respect to personality, self-regulation and performance will be explained in a practical way. In addition to gaining deep insight into their own identity, students will understand how different personalities make up diversity in a team and how this social diversity can be used to boost creativity and collective performance.
This module consists of two parts:
1. The course “Foundations of Pharmaceutical Law” will equip students with a basic theoretical and practical understanding of pharmaceutical law. The focus is drawn on the legal framework of research, development, and marketing of pharmaceuticals. It also covers the legal parameters concerning the economic supply of patients with medicinal products. Gaining familiarity with the key legal aspect to which pharmaceuticals are exposed to shall enable pharmaceutical-focused managers to interact with the relevant company departments and to make successful future decisions in terms of strategy and planning.
2. The course “Foundations of Patent Law” will familiarize students with the basic concepts of intellectual property and provide insight as to different kinds of IP rights, their interaction, on methods and strategies for protection of intellectual property, exploitation of intellectual property rights and their defense and enforcement. It will provide basic legal and practical knowledge in order to enable participants to understand and make decisions regarding IP rights.
The course “Pharmaceutical Value Chain” is about the development and life cycle of medicinal products and the complex and highly regulated process behind it. The course will cover the pharmaceutical value chain from Research & Development, Production and Quality Control to the marketing authorization and pharmacovigilance to the access to the market and reimbursement.
The structure and the content of the Master of Pharma Business Administration are matched to meet the needs of the pharma industry and set the program apart from other education and training formats in the market.
Die Wahlpflichtmodule des Spezialisierungsphase (Electives, wähle 4 x 5 CP) fokussieren sich auf hochaktuelle praxisrelevante pharmaspezifische Inhalte. Angeboten wird ein breites Spektrum an Modulen, aus denen Studierende eine Auswahl je nach persönlichem oder beruflichem Interesse treffen können.
The course “Research, Development & Galenics” will address the wide variety of pharmaceuticals and how this diversity determines their complex development process. Students will gain an understanding of the nature of the research and development process and its different phases, together with the different ways in which a drug is designed, tested and formulated to provide optimal therapeutic benefit. The course will also explore the ethical and regulatory challenges associated with animal studies and clinical trials.
The course will introduce students to major aspects of daily work in Quality Control (QC) / Quality Assurance (QA) organizations of Pharmaceutical Industry. The lessons will provide a working knowledge for attendees to understand requirements resulting from Medicines acts as well as global guidelines along the pharmaceutical products lifecycle. Implementation in day to day work will be discussed as well as the demand of competencies and skills of QC/QA interphase partners.
Medicines or drugs are goods of a very special kind. For example, no efforts in advertisement will make a customer buy an anti-cancer-drug, if he does not suffer from cancer. On the other hand, Paracelsus (1493 - 1541) said “Sola dosis facit venenum”. (“Solely the dose determines whether something is poisonous or not”.) As result, in nearly ALL countries of the world the pharmaceutical market is highly regulated by drug laws. To understand this regulatory system, one needs special knowledge. The course “Regulatory Affairs” will teach students the basic principles to understand the regulatory framework and enable them to communicate with specialists of different faculties (e.g. Drug development, Pharmacology, Toxicology and Regulators or Lawyers in the Competent Authorities).
The course “Pharmacovigilance” will familiarize students with the basic concepts of safety surveillance of medicinal products and its importance related to both public health and “company health”. The module gives the background for why pharmacovigilance is important, and how a good risk management strategy can strengthen the confidence of your company. The module will investigate how pharmacovigilance is embedded in complex pharmaceutical management systems. Furthermore, the module explores various modes of the pharmacovigilance system, including use of strategic partners.
Market Access is a complex process. The so called “fourth hurdle” is for pharmaceuticals an important step on the long road from bench to bedside. “Fourth huddle” because pharmaceuticals already passed the three regulatory hurdles “quality”, “efficacy” and “safety”. To show in addition “efficiency” – a trade-off between health benefits in comparison to existing alternatives and costs - is a major driver for success of new pharmaceuticals. No company providing pharmaceuticals or devices can expect to succeed without designing a Market Access strategy early in the development process. The concept of Market Access requires as much knowledge as professional capabilities. Therefore the course “Market Access and Health Economics” gives students an understanding of the Market Access environment. Core principles of evidence based medicine, Health Technology Assessment and health economics will introduced.
The course “Intrapreneurship and Business Planning” is all about the challenges and trends of the current digital transformation and its implications for the entrepreneurial mindset of employees of mid-sized and larger companies. Shorter product life cycles, disruptive business models or a fully connected and digitalized working environment require new management and organizational capabilities. For all businesses in increasingly competitive ecosystems, issues of how to design and deliver outstanding products and customer experiences become crucial. Traditional management approaches fail periodically when attempting to access the digital transformation. The format "Intrapreneurship and Business Planning" makes use of the methods and procedures of digital startups and transfers it to the context of established companies. Participants will learn what it means to adopt the agility, customer-centric perspective and leadership principles of modern organizations or startups.
Im Anschluss an die dreisemestrige Vorlesungsphase ist das Pflichtmodul „Scientific Methods for Research & Writing“ zu absolvieren, das den Studierenden für die Vorbereitung auf die Masterarbeit notwendige wissenschaftliche Methoden im betriebswirtschaftlichen Kontext vermittelt. Die das Studium abschließende Masterarbeit soll zeigen, dass die oder der Studierende in der Lage ist, innerhalb einer vorgegebenen Frist eine Fragestellung aus einem Fachgebiet des Pharmamanagements selbständig fundiert wissenschaftlich zu bearbeiten und Lösungsvorschläge zu formulieren. Dabei baut die Masterarbeit auf dem während des Studiums erlangten Wissen auf und verbindet dieses mit einer Fragestellung aus der Unternehmenspraxis.